1. Home
  2. STKL vs BCAX Comparison

STKL vs BCAX Comparison

Compare STKL & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKL
  • BCAX
  • Stock Information
  • Founded
  • STKL 1973
  • BCAX 2018
  • Country
  • STKL United States
  • BCAX United States
  • Employees
  • STKL N/A
  • BCAX N/A
  • Industry
  • STKL Precious Metals
  • BCAX
  • Sector
  • STKL Basic Materials
  • BCAX
  • Exchange
  • STKL Nasdaq
  • BCAX NYSE
  • Market Cap
  • STKL 865.2M
  • BCAX 733.5M
  • IPO Year
  • STKL N/A
  • BCAX 2024
  • Fundamental
  • Price
  • STKL $6.98
  • BCAX $13.00
  • Analyst Decision
  • STKL Strong Buy
  • BCAX Strong Buy
  • Analyst Count
  • STKL 4
  • BCAX 6
  • Target Price
  • STKL $9.50
  • BCAX $39.50
  • AVG Volume (30 Days)
  • STKL 395.7K
  • BCAX 327.7K
  • Earning Date
  • STKL 02-26-2025
  • BCAX 03-04-2025
  • Dividend Yield
  • STKL N/A
  • BCAX N/A
  • EPS Growth
  • STKL N/A
  • BCAX N/A
  • EPS
  • STKL N/A
  • BCAX N/A
  • Revenue
  • STKL $711,683,000.00
  • BCAX N/A
  • Revenue This Year
  • STKL $15.65
  • BCAX N/A
  • Revenue Next Year
  • STKL $9.32
  • BCAX N/A
  • P/E Ratio
  • STKL N/A
  • BCAX N/A
  • Revenue Growth
  • STKL 16.96
  • BCAX N/A
  • 52 Week Low
  • STKL $4.88
  • BCAX $11.10
  • 52 Week High
  • STKL $8.11
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • STKL 35.34
  • BCAX N/A
  • Support Level
  • STKL $7.23
  • BCAX N/A
  • Resistance Level
  • STKL $7.68
  • BCAX N/A
  • Average True Range (ATR)
  • STKL 0.22
  • BCAX 0.00
  • MACD
  • STKL -0.04
  • BCAX 0.00
  • Stochastic Oscillator
  • STKL 4.11
  • BCAX 0.00

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: